Previous Article | Next Article ![]()
J. Virol., Mar 1995, 1420-1428, Vol 69, No. 3
OE Obeid, CD Partidos, CR Howard and MW Steward
Synthetic peptides representing T- and B-cell epitopes from the fusion (F)
protein of measles virus (MV) were tested for their ability to induce a
protective immune response against intracerebral challenge with
neuroadapted strains of MV and canine distemper virus (CDV) in mice. Of the
panel of peptides tested, only a chimeric peptide consisting of two copies
of a promiscuous T-cell epitope (representing residues 288 to 302 of MV F
protein) synthesized at the amino terminus of a B-cell epitope
(representing residues 404 to 414 of MV F protein) was able to induce a
protective response against challenge with MV and CDV in inbred mice. The
protective response induced by this peptide (TTB) was associated with a
significant reduction in mortality, histological absence of acute
encephalitis, and greatly reduced titers of virus in the brains of
TTB-immune mice following challenge compared with the results for
nonimmunized controls. A chimeric peptide comprising one copy of the T-cell
epitope and one copy of the B-cell epitope (TB) did not induce a protective
response. A comparison of the antibody responses induced by the two
chimeras suggested that differences in protective efficacy following
immunization may be a result of the higher affinity of the antibody induced
by the TTB peptide than that of the antibody induced by the TB peptide. In
addition, differences in the immunoglobulin G subclass of the antipeptide
antibody responses were observed, and these may play a role in the
differences in protection observed. These results indicate that
appropriately designed synthetic peptides have potential as vaccines for
the induction of cross-reactive protection against morbilliviruses.
Copyright © 1995, American Society for Microbiology
Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus
Department of Clinical Sciences, London School of Hygiene and Tropical Medicine, United Kingdom.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|